Purinergic systems, neuropathic pain and the role of microglia

Research output: Contribution to journalReview article

47 Citations (Scopus)

Abstract

We have learned various data on the role of purinoceptors (P2X4, P2X7, P2Y6 and P2Y12) expressed in spinal microglia and several factors that presumably activate microglia in neuropathic pain after peripheral nerve injury. Purinergic receptor-mediated spinal microglial functions make a critical contribution to pathologically enhanced pain processing in the dorsal horn. Microglial purinoceptors might be promising targets for treating neuropathic pain. A predicted therapeutic benefit of interfering with microglial purinergic receptors may be that normal pain sensitivity would be unaffected since expression or activity of most of these receptors are upregulated or enhanced predominantly in activated microglia in the spinal cord where damaged sensory fibers project.

Original languageEnglish
Pages (from-to)293-301
Number of pages9
JournalExperimental Neurology
Volume234
Issue number2
DOIs
Publication statusPublished - Apr 1 2012

Fingerprint

Purinergic Receptors
Microglia
Neuralgia
Purinergic P2Y12 Receptors
Purinergic P2X4 Receptors
Purinergic P2X7 Receptors
Pain
Peripheral Nerve Injuries
Spinal Cord
Therapeutics

All Science Journal Classification (ASJC) codes

  • Neurology
  • Developmental Neuroscience

Cite this

Purinergic systems, neuropathic pain and the role of microglia. / Inoue, Kazuhide; Tsuda, Makoto.

In: Experimental Neurology, Vol. 234, No. 2, 01.04.2012, p. 293-301.

Research output: Contribution to journalReview article

@article{95f3b4503bb84226873d963544a1c3fd,
title = "Purinergic systems, neuropathic pain and the role of microglia",
abstract = "We have learned various data on the role of purinoceptors (P2X4, P2X7, P2Y6 and P2Y12) expressed in spinal microglia and several factors that presumably activate microglia in neuropathic pain after peripheral nerve injury. Purinergic receptor-mediated spinal microglial functions make a critical contribution to pathologically enhanced pain processing in the dorsal horn. Microglial purinoceptors might be promising targets for treating neuropathic pain. A predicted therapeutic benefit of interfering with microglial purinergic receptors may be that normal pain sensitivity would be unaffected since expression or activity of most of these receptors are upregulated or enhanced predominantly in activated microglia in the spinal cord where damaged sensory fibers project.",
author = "Kazuhide Inoue and Makoto Tsuda",
year = "2012",
month = "4",
day = "1",
doi = "10.1016/j.expneurol.2011.09.016",
language = "English",
volume = "234",
pages = "293--301",
journal = "Experimental Neurology",
issn = "0014-4886",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Purinergic systems, neuropathic pain and the role of microglia

AU - Inoue, Kazuhide

AU - Tsuda, Makoto

PY - 2012/4/1

Y1 - 2012/4/1

N2 - We have learned various data on the role of purinoceptors (P2X4, P2X7, P2Y6 and P2Y12) expressed in spinal microglia and several factors that presumably activate microglia in neuropathic pain after peripheral nerve injury. Purinergic receptor-mediated spinal microglial functions make a critical contribution to pathologically enhanced pain processing in the dorsal horn. Microglial purinoceptors might be promising targets for treating neuropathic pain. A predicted therapeutic benefit of interfering with microglial purinergic receptors may be that normal pain sensitivity would be unaffected since expression or activity of most of these receptors are upregulated or enhanced predominantly in activated microglia in the spinal cord where damaged sensory fibers project.

AB - We have learned various data on the role of purinoceptors (P2X4, P2X7, P2Y6 and P2Y12) expressed in spinal microglia and several factors that presumably activate microglia in neuropathic pain after peripheral nerve injury. Purinergic receptor-mediated spinal microglial functions make a critical contribution to pathologically enhanced pain processing in the dorsal horn. Microglial purinoceptors might be promising targets for treating neuropathic pain. A predicted therapeutic benefit of interfering with microglial purinergic receptors may be that normal pain sensitivity would be unaffected since expression or activity of most of these receptors are upregulated or enhanced predominantly in activated microglia in the spinal cord where damaged sensory fibers project.

UR - http://www.scopus.com/inward/record.url?scp=84858159803&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858159803&partnerID=8YFLogxK

U2 - 10.1016/j.expneurol.2011.09.016

DO - 10.1016/j.expneurol.2011.09.016

M3 - Review article

C2 - 21946271

AN - SCOPUS:84858159803

VL - 234

SP - 293

EP - 301

JO - Experimental Neurology

JF - Experimental Neurology

SN - 0014-4886

IS - 2

ER -